Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.445 USD | +1.71% |
|
+1.08% | -4.95% |
03:09pm | Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug | MT |
Jul. 01 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to Russell Small Cap Comp Value Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.95% | 171M | |
+19.31% | 45.34B | |
+42.95% | 40.42B | |
-9.73% | 37.92B | |
+31.13% | 31.75B | |
-7.79% | 27.71B | |
+13.73% | 26.52B | |
+42.99% | 13.96B | |
+32.04% | 12.44B | |
-7.15% | 11.26B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- Transcript : Outlook Therapeutics, Inc. - Special Call